Form D · Biotechnology

Unnatural Products Inc.

Santa Cruz, CA · CIK 0001788508

Offering snapshot reported Dec 22, 2023 · SEC filing

Reported sold: $25M
Investors reported: 25
Minimum accepted: $0
First sale: Jul 14, 2023

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$17,374,312 → $24,974,312
Reported investors20 → 25

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Dec 22, 2023	Amendment	$24,974,312	$7,600,000vs Jul 28, 2023	25	SEC filing
Jul 28, 2023	Initial	$17,374,312	No comparison	20	SEC filing
Sep 20, 2019	Initial	$5,125,691	No comparison	11	SEC filing

Offering details

Securities: Equity, Option to acquire, Security to be acquired, Other
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-488202

Offering of Series A Preferred Stock and Series A-1 Preferred Stock (together, the Series A) and the underlying shares of Common Stock issuable upon conversion of the Series A.

Source: Form D, filed Dec 22, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Vasudev Bailey	Director
Cameron Pye	Director, Executive
Joshua Schwochert	Executive
Prem Tumkosit	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

2161 Delaware Avenue Suite A
Santa Cruz, CA, 95060